Large Volume Wearable Injectors Market Outlook:
Large Volume Wearable Injectors Market size was over USD 3.22 billion in 2025 and is anticipated to cross USD 7.76 billion by 2035, witnessing more than 9.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of large volume wearable injectors is assessed at USD 3.49 billion.
The growth of the market can be attributed to the rising cases of chronic diseases becoming the major cause of death across the globe. Large-volume wearable injectors are useful to provide drugs over a prolonged time via a subcutaneous route to cure chronic diseases such as cancer and diabetes. As per a recent study in 2020, it was estimated that around 40 million people are killed globally by chronic diseases. Further, it was estimated by the Centers for Disease Control and Prevention that 6 out of 10 adults in the United States are living with one chronic disease, whereas 4 out of 10 adults have been diagnosed with more than two chronic diseases in the year 2022.
Large-volume wearable injectors are drug delivery devices used for the single-step administration of drugs to a lengthier extent. These devices are designed to stick to the patient’s body. A large reservoir is used for storing and delivering a sufficient amount of medications via subcutaneous tissues more quickly and safely. The increasing prevalence of non-communicable diseases among the global population is anticipated to bolster the demand for large-volume wearable injectors over the forecast period. According to a recent World Health Organization (WHO) study published in 2021, non-communicable diseases (NCDs) kill approximately 41 million people worldwide each year. This is equivalent to around 71% of the total global deaths.
